☰

Jie Zhang - Publications

Affiliations: 
Georgia State University, Atlanta, GA, United States 
Tree Info Similar researchers PubMed Report error

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Shan Y, Si R, Wang J, Zhang Q, Li J, Ma Y, Zhang J. Discovery of novel anti-angiogenesis agents. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization. European Journal of Medicinal Chemistry. 205: 112654. PMID 32750566 DOI: 10.1016/J.Ejmech.2020.112654  0.33
2019 Pan X, Liang L, Sun Y, Si R, Zhang Q, Wang J, Fu J, Zhang J, Zhang J. Discovery of novel Bcr-Abl inhibitors with flexible linker. Part 1: Confirmation optimization of phenyl-1H-indazol-3-amine as hinge binding moiety. European Journal of Medicinal Chemistry. 178: 232-242. PMID 31185413 DOI: 10.1016/J.Ejmech.2019.05.091  0.388
2019 Wang J, Chen Q, Shan Y, Pan X, Zhang J. Activity-based proteomic profiling: The application of photoaffinity probes in the target identification of bioactive molecules Trends in Analytical Chemistry. 115: 110-120. DOI: 10.1016/J.Trac.2019.03.028  0.302
2018 Shan Y, Si R, Wang J, Zhang Q, Zhou H, Song J, Zhang J, Chen Q. Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs. European Journal of Medicinal Chemistry. 164: 440-447. PMID 30616052 DOI: 10.1016/J.Ejmech.2018.12.067  0.406
2018 Pan X, Liang L, Si R, Wang J, Zhang Q, Zhou H, Zhang L, Zhang J. Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol. European Journal of Medicinal Chemistry. 163: 1-9. PMID 30503935 DOI: 10.1016/J.Ejmech.2018.11.042  0.403
2018 Zhan Y, Zhang H, Dai B, Zhang Y, Zhang J, He L. A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer. Oncology Reports. PMID 29901176 DOI: 10.3892/Or.2018.6472  0.325
2018 Shan Y, Wang B, Zhang J. New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs. Medicinal Research Reviews. PMID 29878411 DOI: 10.1002/Med.21517  0.483
2017 Zhang L, Shan Y, Ji X, Zhu M, Li C, Sun Y, Si R, Pan X, Wang J, Ma W, Dai B, Wang B, Zhang J. Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget. 8: 104745-104760. PMID 29285210 DOI: 10.18632/Oncotarget.20065  0.507
2017 Li C, Shan Y, Sun Y, Si R, Liang L, Pan X, Wang B, Zhang J. Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4. European Journal of Medicinal Chemistry. PMID 29102175 DOI: 10.1016/J.Ejmech.2017.10.030  0.482
2017 Sun Y, Shan Y, Li C, Si R, Pan X, Wang B, Zhang J. Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors. European Journal of Medicinal Chemistry. 141: 373-385. PMID 29032031 DOI: 10.1016/J.Ejmech.2017.10.008  0.495
2017 Zhang J, Shi Y, Zheng Y, Pan C, Yang X, Dou T, Wang B, Lu W. Homing in on an intracellular target for delivery of loaded nanoparticles functionalized with a histone deacetylase inhibitor. Oncotarget. 8: 68242-68251. PMID 28978112 DOI: 10.18632/Oncotarget.20021  0.432
2017 Wang J, Zhang L, Pan X, Dai B, Sun Y, Li C, Zhang J. Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents. Scientific Reports. 7: 45145. PMID 28332573 DOI: 10.1038/Srep45145  0.398
2017 Zhang L, Shan Y, Li C, Sun Y, Su P, Wang J, Li L, Pan X, Zhang J. Discovery of novel anti-angiogenesis agents. Part 6: Multi-targeted RTK inhibitors. European Journal of Medicinal Chemistry. 127: 275-285. PMID 28068599 DOI: 10.1016/J.Ejmech.2016.12.059  0.413
2015 Wang C, Wang T, Huang L, Lu W, Zhang J, He H. Synthesis and fluorescent study of 5-phenyl furocoumarin derivatives as vasodilatory agents. Bioorganic & Medicinal Chemistry Letters. PMID 26627580 DOI: 10.1016/J.Bmcl.2015.11.056  0.325
2015 Shan Y, Dong J, Pan X, Zhang L, Zhang J, Dong Y, Wang M. Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine. European Journal of Medicinal Chemistry. 104: 139-147. PMID 26451772 DOI: 10.1016/J.Ejmech.2015.09.034  0.384
2015 Shan Y, Gao H, Shao X, Wang J, Pan X, Zhang J. Discovery of novel VEGFR-2 inhibitors. Part 5: Exploration of diverse hinge-binding fragments via core-refining approach. European Journal of Medicinal Chemistry. 103: 80-90. PMID 26342134 DOI: 10.1016/J.Ejmech.2015.08.045  0.416
2015 Dong J, Pan X, Wang J, Su P, Zhang L, Wei F, Zhang J. Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents. European Journal of Medicinal Chemistry. 101: 780-789. PMID 26231079 DOI: 10.1016/J.Ejmech.2015.07.015  0.403
2015 Pan X, Dong J, Shi Y, Shao R, Wei F, Wang J, Zhang J. Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker. Organic & Biomolecular Chemistry. 13: 7050-66. PMID 26052668 DOI: 10.1039/C5Ob00430F  0.379
2015 Shi Y, Zhou M, Zhang J, Lu W. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles. Journal of Microencapsulation. 1-6. PMID 26004370 DOI: 10.3109/02652048.2015.1035683  0.311
2015 Su P, Wang J, Shi Y, Pan X, Shao R, Zhang J. Discovery of biphenyl-aryl ureas as novel VEGFR-2 inhibitors. Part 4: Exploration of diverse hinge-binding fragments. Bioorganic & Medicinal Chemistry. 23: 3228-36. PMID 25982075 DOI: 10.1016/J.Bmc.2015.04.071  0.388
2015 Lu W, Li P, Shan Y, Su P, Wang J, Shi Y, Zhang J. Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: design, synthesis and 3D-QSAR studies. Bioorganic & Medicinal Chemistry. 23: 1044-54. PMID 25637123 DOI: 10.1016/J.Bmc.2015.01.006  0.408
2015 Gao H, Su P, Shi Y, Shen X, Zhang Y, Dong J, Zhang J. Discovery of novel VEGFR-2 inhibitors. Part II: biphenyl urea incorporated with salicylaldoxime. European Journal of Medicinal Chemistry. 90: 232-40. PMID 25461323 DOI: 10.1016/J.Ejmech.2014.11.032  0.371
2014 Dong J, Lu W, Pan X, Su P, Shi Y, Wang J, Zhang J. Discovery of novel Bcr-Abl inhibitors targeting myristoyl pocket and ATP site. Bioorganic & Medicinal Chemistry. 22: 6876-84. PMID 25464886 DOI: 10.1016/J.Bmc.2014.10.030  0.346
2014 Dai B, Qi J, Liu R, Zhang J, Zhan Y, Zhang Y. A novel compound T7 (N-{4'-[(1E)-N-hydroxyethanimidoyl]-3',5,6-trimethoxybiphenyl-3-yl}-N'-[4-(3-morpholin-4-ylpropoxy)phenyl]urea) screened by tissue angiogenesis model and its activity evaluation on anti-angiogenesis. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 21: 1675-83. PMID 25442276 DOI: 10.1016/J.Phymed.2014.08.005  0.343
2014 Lu W, Wang F, Zhang T, Dong J, Gao H, Su P, Shi Y, Zhang J. Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives. Bioorganic & Medicinal Chemistry. 22: 2707-13. PMID 24702857 DOI: 10.1016/J.Bmc.2014.03.019  0.365
2014 Pan X, Dong J, Gao H, Wang F, Zhang Y, Wang S, Zhang J. Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors. Chemical Biology & Drug Design. 83: 592-9. PMID 24330598 DOI: 10.1111/Cbdd.12272  0.367
2014 Wang C, Gao H, Dong J, Zhang Y, Su P, Shi Y, Zhang J. Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 22: 277-84. PMID 24315192 DOI: 10.1016/J.Bmc.2013.11.027  0.393
2014 Wang C, Gao H, Dong J, Wang F, Li P, Zhang J. Insight into the medicinal chemistry of EGFR and HER-2 inhibitors. Current Medicinal Chemistry. 21: 1336-1350. PMID 24251571 DOI: 10.2174/0929867320666131119124646  0.326
2013 Fu J, Cheng Y, Linghu J, Yang X, Kang L, Zhang Z, Zhang J, He C, Du X, Peng Z, Wang B, Zhai L, Dai C, Xu J, Wang W, et al. RNA sequencing reveals the complex regulatory network in the maize kernel. Nature Communications. 4: 2832. PMID 24343161 DOI: 10.1038/ncomms3832  0.357
2013 Wang F, Lu W, Zhang T, Dong J, Gao H, Li P, Wang S, Zhang J. Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry. 21: 6973-80. PMID 24095016 DOI: 10.1016/J.Bmc.2013.09.021  0.379
2013 Luo W, Wang X, Zheng L, Zhan Y, Zhang D, Zhang J, Zhang Y. Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway. Journal of Cellular and Molecular Medicine. 17: 1316-24. PMID 23905676 DOI: 10.1111/Jcmm.12108  0.342
2013 Zhou N, He JY, Wang T, Zhang J, He HZ. Design, synthesis, and vasorelaxation activity of novel imperatorin derivatives. Journal of Asian Natural Products Research. 15: 650-7. PMID 23659576 DOI: 10.1080/10286020.2013.790378  0.343
2013 Pan X, Wang F, Zhang Y, Gao H, Hu Z, Wang S, Zhang J. Design, synthesis and biological activities of Nilotinib derivates as antitumor agents. Bioorganic & Medicinal Chemistry. 21: 2527-34. PMID 23538233 DOI: 10.1016/J.Bmc.2013.02.036  0.377
2013 Wang C, Dong J, Zhang Y, Wang F, Gao H, Li P, Wang S, Zhang J. Design, synthesis and biological evaluation of biphenyl urea derivatives as novel VEGFR-2 inhibitors Medchemcomm. 4: 1434. DOI: 10.1039/C3Md00192J  0.356
2012 He H, Wang N, Zhang J, Zheng L, Zhang Y. Tas13D Inhibits Growth of SMMC-7721 Cell via Suppression VEGF and EGF Expression Asian Pacific Journal of Cancer Prevention. 13: 2009-2014. PMID 22901163 DOI: 10.7314/Apjcp.2012.13.5.2009  0.376
2012 Zhang J, Zhang Y, Pan X, Wang C, Hu Z, Wang S, He L. Facile synthesis and biological evaluation of novel symmetrical biphenyls as antitumor agents. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 8: 145-50. PMID 22385184 DOI: 10.2174/157340612800493656  0.399
2012 He H, Han S, Zhang T, Zhang J, Wang S, Hou J. Screening active compounds acting on the epidermal growth factor receptor from Radix scutellariae via cell membrane chromatography online coupled with HPLC/MS. Journal of Pharmaceutical and Biomedical Analysis. 62: 196-202. PMID 22260968 DOI: 10.1016/J.Jpba.2011.12.025  0.332
2011 Pan X, Wang C, Wang F, Li P, Hu Z, Shan Y, Zhang J. Development of 5-Fluorouracil derivatives as anticancer agents. Current Medicinal Chemistry. 18: 4538-56. PMID 21864282 DOI: 10.2174/092986711797287584  0.328
2011 Zhang J, Shan Y, Pan X, He L. Recent Advances in Antiangiogenic Agents with VEGFR as Target Mini-Reviews in Medicinal Chemistry. 11: 920-946. PMID 21762098 DOI: 10.2174/138955711797068355  0.352
2011 Zhang J, Shan Y, Pan X, Wang C, Xu W, He L. Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-aminosalicylic acid derivatives as neuraminidase inhibitors. Chemical Biology & Drug Design. 78: 709-717. PMID 21752201 DOI: 10.1111/J.1747-0285.2011.01179.X  0.321
2011 Zhang Y, Zheng L, Zhang J, Dai B, Wang N, Chen Y, He L. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo. Planta Medica. 77: 1774-81. PMID 21614750 DOI: 10.1055/S-0030-1271132  0.319
2011 Zhang J, Zhang Y, Pan X, Wang S, He L. Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents. Medicinal Chemistry (Shariqah (United Arab Emirates)). 7: 286-94. PMID 21568882 DOI: 10.2174/157340611796150914  0.394
2011 Li N, He J, Zhan Y, Zhou N, Zhang J. Design, synthesis and preliminary evaluation of novel imperatorin derivatives as vasorelaxant agents. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 7: 18-23. PMID 21235515 DOI: 10.2174/157340611794072715  0.382
2011 Sun M, Zhang Y, Zhang J, Wang S, He L. A high expression EGFR/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening EGFR antagonists from Rhizoma Polygoni Cuspidati Acta Pharmaceutica Sinica B. 1: 115-120. DOI: 10.1016/J.Apsb.2011.06.008  0.304
2010 Zhang J, Zhang Y, Shan Y, Li N, Ma W, He L. Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents. European Journal of Medicinal Chemistry. 45: 2798-805. PMID 20304537 DOI: 10.1016/J.Ejmech.2010.03.001  0.394
2010 Zhang J, Zhang Y, Zhang S, Wang S, He L. Corrigendum to “Discovery of novel taspine derivatives as antiangiogenic agents” [Bioorg. Med. Chem. Lett. 20 (2010) 718] Bioorganic & Medicinal Chemistry Letters. 20: 1797. DOI: 10.1016/J.Bmcl.2010.01.026  0.311
2009 Zhang J, Zhang Y, Zhang S, Wang S, He L. Discovery of novel taspine derivatives as antiangiogenic agents. Bioorganic & Medicinal Chemistry Letters. 20: 718-21. PMID 20006929 DOI: 10.1016/J.Bmcl.2009.11.073  0.406
2008 Zhang J, Xu W, Liu A, Du G. Design, synthesis, and preliminary evaluation of new pyrrolidine derivatives as neuraminidase inhibitors. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 4: 206-9. PMID 18473912 DOI: 10.2174/157340608784325151  0.367
2008 Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 16: 5473-81. PMID 18467109 DOI: 10.1016/J.Bmc.2008.04.012  0.447
2008 Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 16: 3839-47. PMID 18304821 DOI: 10.1016/J.Bmc.2008.01.036  0.345
2007 Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 15: 2749-58. PMID 17287121 DOI: 10.1016/J.Bmc.2007.01.020  0.36
2006 Zhang L, Zhang J, Fang H, Wang Q, Xu W. Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors. Bioorganic & Medicinal Chemistry. 14: 8286-94. PMID 17008101 DOI: 10.1016/J.Bmc.2006.09.015  0.363
Show low-probability matches.